Table 1.
Screen | Baseline | 4 weeks | 8 weeks | 12 weeks | 16 weeks | 20 weeks | |
---|---|---|---|---|---|---|---|
Eligibility: | |||||||
MFQ-C | X | ||||||
DIAS-C | X | ||||||
Treatment Timeline | |||||||
ICP | ■ | ------- | ------- | ------- | ------- | ■ | |
Treatment as usual | ■ | ------- | ------- | ------- | ------- | ■ | |
Sample Description Measures | |||||||
Demographics Form | X | ||||||
Treatment History Form | X | ||||||
Feasibility Outcomes | |||||||
Time to complete baseline measures | X | ||||||
ICP Adherence measure | X | X | X | X | X | X | |
Overall CARIBOU Study Outcome Measures | |||||||
CDRS-R | X | X | X | X | X | X | |
WHODAS | X | X | X | X | X | X | |
CBCL | X | X | X | X | X | X | |
Measurement-based Care Measures | |||||||
MFQ-C | X | X | X | X | X | X | |
YCIS | X | X | X | X | X | X | |
PCIS | X | X | X | X | X | X | |
MFAD-GF | X | Xa | Xa | Xa | Xa | Xa |
X = assessment to be completed; ■ = beginning or end of treatment; a = only if baseline MFAD above established cut-off.